View Article

Abstract

Pharmacovigilance (PV) is a relatively new discipline in the pharmaceutical industry. Having undergone rapid growth over the past 2 decades, PV now touches many other disciplines in the research and development enterprise. With its growth has come a heightened awareness and interest in the medical community about the roles that PV plays. This article provides insights into the background and inner workings of PV. Pharmacovigilance plays a pivotal role in ensuring the safety of pharmaceutical products throughout their lifecycle. This comprehensive review explores the multifaceted landscape of pharmacovigilance, focusing on its integral role in enhancing drug safety and surveillance. The review begins by elucidating the fundamental concepts of pharmacovigilance, emphasizing its significance in identifying, assessing, and preventing adverse drug reactions (ADRs). It delves into the historical evolution of pharmacovigilance, tracing its development from a reactive post-marketing activity to a proactive and integrated system. All healthcare providers have roles to play in maintaining a balance between a medicine's benefits and risks. Once a drug is available to the public, making a determination about its safety is the shared responsibility of all who are part of the prescribing process, including patients. The role of healthcare professionals is vital in recording and reporting suspected ADRs in order that regulatory agencies are alerted of emerging safety concerns and thereby facilitating timely and appropriate action. As a part of health care team every pharmacist must have knowledge about adverse drug reaction monitoring systems and pharmacovigilance

Keywords

Adverse drug reaction, Pharmacovigilance, Post marketing activity , drug safety and surveillance

Reference

  1. Beninger P. Pharmacovigilance: an overview. Clinical therapeutics. 2018 Dec 1;40(12):1991-2004.
  2. Maqbool M, Dar MA, Rasool S, Bhat AU, Geer MI. Drug safety and Pharmacovigilance: An overview. Journal of Drug Delivery and Therapeutics. 2019 Apr 15;9(2-s):543-8.
  3. Hans M, Gupta SK. Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices. Perspectives in clinical research. 2018 Oct;9(4):170
  4. Meyboom RH, Egberts AC, Gribnau FW, Hekster YA. Pharmacovigilance in perspective. Drug safety. 1999 Dec;21:429
  5. Peters T, Soanes N, Abbas M, Ahmad J, Delumeau JC, Herrero-Martinez E, Paramananda M, Piper J, Smail-Aoudia F, van der Spuij W, Veizovic T. Effective pharmacovigilance system development: EFPIA-IPVG consensus recommendations. Drug safety. 2021 Jan;44:17-28.
  6. Bihan K, Lebrun-Vignes B, Funck-Brentano C, Salem JE. Uses of pharmacovigilance databases: an overview. Therapies. 2020 Nov 1;75(6):591-8.
  7. Fouretier A, Malriq A, Bertram D. Open access pharmacovigilance databases: analysis of 11 databases. Pharmaceutical medicine. 2016 Aug;30:221-31.
  8. Trifirò G, Sultana J, Bate A. From big data to smart data for pharmacovigilance: the role of healthcare databases and other emerging sources. Drug safety. 2018 Feb;41:143-9.
  9. Kavitha D. Adverse drug reaction (ADR) monitoring and pharmacovigilance. J Pharm Res Health Care. 2010 Jan 1;2:127-34.
  10. KUMAR DN, Prasanth Y, Narendra B, Upendra K, Rajesh K. A review on Adverse drug reactions monitoring andreporting. International Journal of Pharmacy Research & Technology (IJPRT). 2019;9(2):12-5.
  11. Kharkar M, Bowalekar S. Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspectives in clinical research. 2012 Jul;3(3):90.
  12. Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clinical epidemiology. 2009 Aug 9:75-92.
  13. Ibrahim H, Abdo A, El Kerdawy AM, Eldin AS. Signal detection in pharmacovigilance: a review of informatics-driven approaches for the discovery of drug-drug interaction signals in different data sources. Artificial Intelligence in the Life Sciences. 2021 Dec 1;1:100005.
  14. Shibata A, Hauben M. Pharmacovigilance, signal detection and signal intelligence overview. In14th International Conference on Information Fusion 2011 Jul 5 (pp. 1-7). IEEE.
  15. Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont?Salamé G, Catania MA, Salvo F, David A, Moore N, Caputi AP. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?. Pharmacoepidemiology and drug safety. 2009 Dec;18(12):1176-84.
  16. Lu?i? MM, Miloševi? NP, Marti? NB, Paut KM, Jovan?evi? VM, Ubavi? MB, Todorovi? NB, Kraja?i? DJ, Raškovi? AL. The role of a pharmacist in pharmacovigilance system. Hospital Pharmacology-International Multidisciplinary Journal. 2018;5(3):715-27.
  17. Salehifar E, Ala S, Amini M, Azhdari E, Mir-Shafa F. The role of clinical pharmacists in the improvement of a pharmacovigilance system: a review of the reported adverse drug reactions during 2004-2010 in Mazandaran Province of Iran. Journal of Pharmaceutical Care. 2013:8-12.
  18. Hadi MA, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integrated Pharmacy Research and Practice. 2017 Mar 22:91-8

Photo
Arkaydius Jyndiang
Corresponding author

Department of Pharmacy practice, Srinivas College of Pharmacy, Valachil Mangalore 574143

Photo
A. R. Shabaraya
Co-author

Department of Pharmacy practice, Srinivas College of Pharmacy, Valachil Mangalore 574143

Photo
Viresh K. Chandur
Co-author

Department of Pharmacy practice, Srinivas College of Pharmacy, Valachil Mangalore 574143

Arkaydius Jyndiang*, A. R. Shabaraya, Viresh K. Chandur Review A Comprehensive Review On Pharmacovigilance: Enhancing Drug Safety And Surveillance, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12, 158-165. https://doi.org/10.5281/zenodo.10302560

More related articles
Analytical Optimization Of 1,2,4-Triazole Derivati...
Jisha M. S., Prasanth V. V., Karmvir, ...
Pharmacological Assessment Of Formononetin On Beha...
Dr. Manojkumar Mahajan, Roshan wagh, Sumitkumar Sharma, Sunil Pan...
A Review on Diabetes Mellitus...
Jagruti G. Musale, Dikshita D. Wagh, Rishikesh S. Bachhav, Smita ...
Recent Progress In Metal Organic Framework As Drug Delivery Platform...
Sagar A Sarode, Yogesh N Sonawane, Mayuri A Sarode, Parag R Patil, Adityaraj D Kumbhar, Vaishali A P...
UPLC-MS Method Development and Validation for Fluticasone Propionate: A Comprehe...
Vishweshwari Bhagat, Monali Khatake, Mansi Shelke, Tanvi Kambale, Nikita Pabale, Dnyaneshwari Kurhe...
Detection Of Diseases And Predictive Analytic...
Hariom Rajput, Sanoop Kumar Tiwari, , ...
Related Articles
Neuroprotective Effects of Hydroalcoholic Extract of Dracaena Reflexa Leaves in ...
Ajna P. A., Prabitha E.G., Anjali U., Binil Raj S. S., ...
A Prospective Study On Cost Of Illness Among Hypertensive Inpatients At A Tertia...
Shreeraksha K., Ramakrishna Shabaraya A., Suchetha Kumari, ...
Effective Communication In Pharmacovigilance...
Prajakta Pujari , Sonali Magdum, Kajal Shinde, Darshani Taral, Prajakta Chaugule, Sadhana Pujari, Ra...
More related articles
Pharmacological Assessment Of Formononetin On Behavior, Cognitive Function And O...
Dr. Manojkumar Mahajan, Roshan wagh, Sumitkumar Sharma, Sunil Pandit, Dr. Aman Upaganlwar, Dr. Chand...
A Review on Diabetes Mellitus...
Jagruti G. Musale, Dikshita D. Wagh, Rishikesh S. Bachhav, Smita S. Aher, ...
Pharmacological Assessment Of Formononetin On Behavior, Cognitive Function And O...
Dr. Manojkumar Mahajan, Roshan wagh, Sumitkumar Sharma, Sunil Pandit, Dr. Aman Upaganlwar, Dr. Chand...
A Review on Diabetes Mellitus...
Jagruti G. Musale, Dikshita D. Wagh, Rishikesh S. Bachhav, Smita S. Aher, ...